Drug Type Small molecule drug |
Synonyms Triamterene and Hydrochlorothiazide, 氢氯噻嗪/氨苯蝶啶, Dyazide + [2] |
Target |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (02 Dec 1965), |
Regulation- |
Molecular FormulaC19H19ClN10O4S2 |
InChIKeyXZRKEDHJXXLVSK-UHFFFAOYSA-N |
CAS Registry14124-50-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Edema | US | 22 Oct 1984 | |
Hypertension | US | 22 Oct 1984 |
Not Applicable | 1 | nvyloxlouq(tcucsfdgbx) = A diagnosis of acute nephrogenic diabetes insipidus (NDI) was made vxjhzbeobx (ksslurfzvp ) View more | Positive | 05 Nov 2013 | |||
Not Applicable | - | (plksueyxlm) = slomtuqyzm xvfalisfbz (sqkpncubeq ) | Negative | 30 Oct 2012 | |||
Hydrochlorothiazide (HCTZ) | (plksueyxlm) = keqglgjlxw xvfalisfbz (sqkpncubeq ) |